Lipigon Pharmaceuticals AB
A clinical-stage company developing therapeutics for lipid-related disorders.
LPGO | ST
Overview
Corporate Details
- ISIN(s):
- SE0015382072
- LEI:
- 549300XPO40YR12SLY87
- Country:
- Sweden
- Address:
- Tvistevägen 48 C, 907 36 Umeå
- Website:
- https://lipigon.se/
Description
Lipigon Pharmaceuticals is a clinical-stage company specializing in lipid biology, focused on developing novel therapeutics for diseases related to lipid disorders and cardio-metabolic risk factors. The company's lead drug candidate, Lipisense®, is in clinical development for lowering blood triglyceride levels. Lipisense® utilizes a unique mechanism of action to address high blood fats, which are a significant risk factor for cardiovascular disease. The company's pipeline is founded on extensive research in blood lipid regulation, aiming to provide new treatment options for patients with conditions such as severe hypertriglyceridemia and other lipid-related disorders where a significant unmet medical need exists.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Lipigon Pharmaceuticals AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Lipigon Pharmaceuticals AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Lipigon Pharmaceuticals AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-16 | Johan Living | Other | Buy | 260,000 | 51,688.00 SEK |
Peer Companies
